Changes in caudate volume with neuroleptic treatment

MIR137 polygenic risk for schizophrenia and ephrin-regulated pathway: Role in lateral ventricles and corpus callosum volume.

International journal of clinical and health psychology : IJCHP·2024

Anhedonia in adolescents at transdiagnostic familial risk for severe mental illness: Clustering by symptoms and mechanisms of association with behavior.

Journal of affective disorders·2023

Emotional scene processing in biotypes of psychosis.

Psychiatry research·2023

An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).

Schizophrenia research·2019

Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.

Translational psychiatry·2017

Deviation from expected cognitive ability across psychotic disorders.

Schizophrenia research·2017

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The Therapeutic Potential of Phaseolus vulgaris in Alzheimer's Disease: Insights From Experimental Rodent Model.

Scientifica·2026

Diindolylmethane confers nootropic and neuroprotection effects against scopolamine-induced brain injury in Wistar rats.

3 Biotech·2026

Differential analysis of ginseng methanol extracts from different origins using FTIR and 2D-COS-IR spectroscopies.

Analytical methods : advancing methods and applications·2026

Design Strategies for Developing Chiral Macrocyclic Chelators as a Diagnostic Tool.

Accounts of chemical research·2026

ADAPT-M: a workflow for rapid, quantitative in vitro measurements of enriched protein libraries.

Nature communications·2026

Integrating Suspect and Nontargeted Screening for Food Safety Testing: A Case Study of Bee Pollen Supplements.

Analytical chemistry·2026

Related Experiment Videos

Changes in caudate volume with neuroleptic treatment

Related Concept Videos

MIR137 polygenic risk for schizophrenia and ephrin-regulated pathway: Role in lateral ventricles and corpus callosum volume.

Anhedonia in adolescents at transdiagnostic familial risk for severe mental illness: Clustering by symptoms and mechanisms of association with behavior.

Emotional scene processing in biotypes of psychosis.

An integrated neurocognitive and social-cognitive treatment for youth at clinical high risk for psychosis: Cognition for Learning and for Understanding Everyday Social Situations (CLUES).

Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.

Deviation from expected cognitive ability across psychotic disorders.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The Therapeutic Potential of Phaseolus vulgaris in Alzheimer's Disease: Insights From Experimental Rodent Model.

Diindolylmethane confers nootropic and neuroprotection effects against scopolamine-induced brain injury in Wistar rats.

Differential analysis of ginseng methanol extracts from different origins using FTIR and 2D-COS-IR spectroscopies.

Design Strategies for Developing Chiral Macrocyclic Chelators as a Diagnostic Tool.

ADAPT-M: a workflow for rapid, quantitative in vitro measurements of enriched protein libraries.

Integrating Suspect and Nontargeted Screening for Food Safety Testing: A Case Study of Bee Pollen Supplements.

Related Experiment Videos

Changes in caudate volume with neuroleptic treatment

Related Concept Videos

Related Articles